Aripiprazole augmentation in the management of residual symptoms in clozapine-treated outpatients with chronic schizophrenia: An open-label pilot study-Reference-Cited by-同舟云学术

Aripiprazole augmentation in the management of residual symptoms in clozapine-treated outpatients with chronic schizophrenia: An open-label pilot study

Published:2007-03 Issue:2 Volume:31 Page:373-377
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Mitsonis Charalampos I.,Dimopoulos Nikolaos P.,Mitropoulos Panagiotis A.,Kararizou Evangelia G.,Katsa Alexandra N.,Tsakiris Fivos E.,Katsanou Maria Nefeli E.

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference33 articles.

1. Abnormal Involuntary Movement Scale (AIMS),1976

2. Atypical antipsychotic induced weight gain: pathophysiology and management;Ananth;Ann Clin Psychiatry,2004

3. A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety;Anil Yagcioglu;J Clin Psychiatry,2005

4. Patient response and resource management: another view of clozapine treatment of schizophrenia;Carpenter;Am J Psychiatry,1995

5. Detecting improvement in quality of life and symptomatology in schizophrenia;Cramer;Schizophr Bull,2001

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Situation du parcours de réhabilitation concernant les patients hospitalisés au long cours. À partir d’une analyse clinique et catamnestique de 75 cas;Médecine & Droit;2023-12

2. Efficacy of Serotonin and Dopamine Activity Modulators in the Treatment of Negative Symptoms in Schizophrenia: A Rapid Review;Biomedicines;2023-03-16

3. Third-generation antipsychotics in patients with schizophrenia and non-responsivity or intolerance to clozapine regimen: What is the evidence?;Frontiers in Psychiatry;2022-11-29

4. Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus study;BMC Psychiatry;2022-05-28

5. Characteristics and definitions of ultra-treatment-resistant schizophrenia – A systematic review and meta-analysis;Schizophrenia Research;2021-02